Citation only
via OpenAlex
Metformin as a geroprotector: experimental and clinical evidence
Veronika Piskovatska, Nadya Stefanyshyn, Kenneth B. Storey, Alexander Vaiserman, Oleh Lushchak
Biogerontology · 2018 · ▲ 111 citations
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1007/s10522-018-9773-5
- Canonical
- link ↗
- Fetched
- 2026-06-13 MST
Cite this
APA
Piskovatska, V., Stefanyshyn, N., Storey, K.B., Vaiserman, A., & Lushchak, O. (2018). Metformin as a geroprotector: experimental and clinical evidence. <em>Biogerontology</em>. https://doi.org/10.1007/s10522-018-9773-5
Vancouver
Piskovatska V, Stefanyshyn N, Storey KB, Vaiserman A, Lushchak O. Metformin as a geroprotector: experimental and clinical evidence. Biogerontology. 2018. doi:10.1007/s10522-018-9773-5.
BibTeX
@article{veronika2018Metfor,
title = {Metformin as a geroprotector: experimental and clinical evidence},
author = {Veronika Piskovatska and Nadya Stefanyshyn and Kenneth B. Storey and Alexander Vaiserman and Oleh Lushchak},
journal = {Biogerontology},
year = {2018},
doi = {10.1007/s10522-018-9773-5},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Mechanisms of Ageing and Development 2020
Preprint · CC-BY
Is metformin a geroprotector? A peek into the current clinical and experimental data
GeroScience 2023
Preprint · OA
Blazing a trail for the clinical use of rapamycin as a geroprotecTOR
European Journal of Plastic Surgery 2024
Citation only
The anti-aging role of metformin, clinical applications to pursue the longevity road
Journal of Biological Chemistry 2014
Open access · CC-BY
Low Concentrations of Metformin Suppress Glucose Production in Hepatocytes through AMP-activated Protein Kinase (AMPK)*
Circulation Research 2023
Open access · OA
Critical Role of the cGAS-STING Pathway in Doxorubicin-Induced Cardiotoxicity
Oklahoma Medical Research Foundation 2020
Open access · US-GOV